↓ Skip to main content

American Association for Cancer Research

Navitoclax (ABT-263) Reduces Bcl-xL–Mediated Chemoresistance in Ovarian Cancer Models

Overview of attention for article published in Molecular Cancer Therapeutics, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
77 Mendeley
citeulike
1 CiteULike
Title
Navitoclax (ABT-263) Reduces Bcl-xL–Mediated Chemoresistance in Ovarian Cancer Models
Published in
Molecular Cancer Therapeutics, April 2012
DOI 10.1158/1535-7163.mct-11-0693
Pubmed ID
Authors

Maureen Wong, Nguyen Tan, Jiping Zha, Franklin V. Peale, Peng Yue, Wayne J. Fairbrother, Lisa D. Belmont

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Italy 1 1%
Unknown 75 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 38%
Student > Ph. D. Student 17 22%
Student > Bachelor 8 10%
Student > Master 6 8%
Student > Doctoral Student 3 4%
Other 6 8%
Unknown 8 10%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 26%
Agricultural and Biological Sciences 19 25%
Medicine and Dentistry 7 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Engineering 3 4%
Other 10 13%
Unknown 13 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#2,941,107
of 26,017,215 outputs
Outputs from Molecular Cancer Therapeutics
#381
of 4,112 outputs
Outputs of similar age
#17,892
of 177,719 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#11
of 55 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,112 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.